Toggle Offcanvas
...
 
Brinzolamide Tenders

Brinzolamide Tenders

View Brinzolamide tenders, RFPs and contracts. Bid on readily available Brinzolamide tenders with the best and most comprehensive tendering platform, since 2002.
Brinzolamide is an ophthalmic medication that helps lower eye pressure in glaucoma and ocular hypertension. It works by inhibiting an enzyme called carbonic anhydrase, which reduces fluid production inside the eye.

Bidding for Brinzolamide tenders is extremely lucrative for companies of all sizes. Tendering authorities and private companies release thousands of contracts worth millions for procurement of Brinzolamide.

Global Tenders stands out as the largest platform dedicated to pharmaceutical tenders and government contracts. Boasting over 20 years of experience in the tender business, GlobalTenders offers the most extensive and reliable Tenders/RFPs/Contracts Database available. The platform aggregates contracts from both public and private sources, connecting with a vast network of over half a million buyers. Employing advanced artificial intelligence, our meticulous process involves gathering information from over a hundred thousand sources. The data is then intelligently categorized into thousands of subcategories for easy filtering and presenting it in a user-friendly format for quick comprehension.

In addition to tender information, we offer in-depth Brinzolamide market analysis, bid consultancy services, and insights into top bidders and winners.

Sign up now to get instant access to unlimited Brinzolamide tenders, advanced search filters, market analysis, industry trends, tender training and 24/7 customer support.

144 Live Notices for Brinzolamide Tenders

Showing 1 to 20

Object: Electronic Auction - Potential Acquisition Of Medicines (S) Belonging To Group: 09.D.01.B - Antifungals For Systemic Use, Group: 09.S.01.E - Prepared Antiglaucoma And Myiotics, Group: 2204 - Cosmetics, Group: 09.S.01.X - Other Ophthalmologicals, Group: 09.D.07.A - Isolated Corticosteroids And Group: 09.B.05.X - Advorate Solution Additives, In Price Registration System, To Meet The Needs Of The Health Department Df.
country Brazil
posting date08 Aug 2025
deadline22 Aug 2025
Open House Pharmaceutical Dact Treaties Brinzolamid And Brimonidin, Atc S01Ec24
country Germany
posting date16 Jun 2025
deadline03 Jun 2027
Open House Pharmaceutical Dact Treaties Brinzolamid And Brimonidin, Atc S01Ec24
country Germany
posting date16 Jun 2025
deadline03 Jun 2027
Open House Pharmaceutical Dact Treaties Brinzolamid And Brimonidin, Atc S01Ec24
country Germany
posting date18 Feb 2025
deadline05 Feb 2027
Conclusion Of A Non-Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Combination Of Brinzolamide And Timolol (Atc: S01Ed67).
country Germany
posting date24 Jan 2025
deadline28 Dec 2026
Medicines Containing The Active Ingredient Combination Brinzolamide And Brimonidine (Atc: S01Ec24)
country Germany
posting date21 Jan 2025
deadline31 Dec 2026
Conclusion Of A Non-Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Combination Of Brinzolamide And Timolol (Atc: S01Ed67).
country Germany
posting date09 Jan 2025
deadline28 Dec 2026
Conclusion Of Non-Exclusive Discount Agreements According To §130A Para.8 Sgb V For Various Active Ingredients/Combinations With The Possibility Of Conclusion At Any Time Within The Framework Of The So-Called Open House Procedure
country Germany
posting date05 Dec 2024
deadline05 Dec 2026
Conclusion Of Non-Exclusive Discount Agreements According To §130A Para.8 Sgb V For Various Active Ingredients/Combinations With The Possibility Of Conclusion At Any Time Within The Framework Of The So-Called Open House Procedure
country Germany
posting date26 Nov 2024
deadline05 Dec 2026
Open House Discount Agreements 2024-13
country Germany
posting date15 Nov 2024
deadline31 Dec 2026
Medicines Containing The Active Ingredient Combination Brinzolamide And Timolol (Atc: S01Ed67)
country Germany
posting date13 Nov 2024
deadline31 Oct 2026
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Brinzolamide/Timolol (Official Atc Code: S01Ed67)
country Germany
posting date11 Nov 2024
deadline31 Dec 2026
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Brinzolamide/Timolol (Official Atc Code: S01Ed67)
country Germany
posting date11 Nov 2024
deadline31 Dec 2026
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Brinzolamide/Timolol (Official Atc Code: S01Ed67)
country Germany
posting date11 Nov 2024
deadline31 Dec 2026
Conclusion Of A Non-Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Combination Of Brinzolamide And Brimonidine (Atc Code: S01Ec24).
country Germany
posting date30 Oct 2024
deadline27 Oct 2026
Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredients Brinzolamide And Brimonidine (S01Ec24) Within The Framework Of A So-Called Open-House Model.
country Germany
posting date12 Oct 2024
deadline30 Sep 2026
Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredients Brinzolamide And Brimonidine (S01Ec24) Within The Framework Of A So-Called Open-House Model.
country Germany
posting date12 Oct 2024
deadline30 Sep 2026
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Timolol + Brinzolamide, Atc S01Ed67 (Obg) For The Period 01.11.2024 - 31.10.2026
country Germany
posting date17 Sep 2024
deadline05 Sep 2026
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Timolol + Brinzolamide, Atc S01Ed67 (Obg) For The Period 01.11.2024 - 31.10.2026
country Germany
posting date17 Sep 2024
deadline05 Sep 2026
Pharmaceutical Discount Agreements From 1 November 2024 For Various Active Ingredients As Part Of An Open House Procedure
country Germany
posting date09 Sep 2024
deadline01 Sep 2026

Share Share this page